TY - JOUR
T1 - Prolonged partial thromboplastin time
T2 - To mix or not to mix – is that the question?
AU - Yates, Sean G.
AU - Fitts, Eric
AU - De Simone, Nicole
AU - Sarode, Ravi
N1 - Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2019/2
Y1 - 2019/2
N2 - Routine mixing studies are frequently used to evaluate patients presenting with prolonged partial thromboplastin times (PTT) and/or prothrombin times (PT). Unfortunately, mixing studies have a number of inherent limitations including lack of standardization in terms of what defines normal pooled plasma (NPP), the processing of a patient's plasma for platelet removal (platelet poor plasma versus platelet-free plasma), performance of appropriate controls, conducting an incubation step to evaluate for a time and temperature dependent inhibitor, and finally interpretation of test results. Moreover, misinterpretation of study results can lead to a delayed or incorrect diagnosis or worse, inappropriate treatment. Within this manuscript, we present four cases illustrating the shortcomings associated with inappropriate utilization and interpretation of routine mixing studies; and present practical steps for managing abnormal PT or PTT results.
AB - Routine mixing studies are frequently used to evaluate patients presenting with prolonged partial thromboplastin times (PTT) and/or prothrombin times (PT). Unfortunately, mixing studies have a number of inherent limitations including lack of standardization in terms of what defines normal pooled plasma (NPP), the processing of a patient's plasma for platelet removal (platelet poor plasma versus platelet-free plasma), performance of appropriate controls, conducting an incubation step to evaluate for a time and temperature dependent inhibitor, and finally interpretation of test results. Moreover, misinterpretation of study results can lead to a delayed or incorrect diagnosis or worse, inappropriate treatment. Within this manuscript, we present four cases illustrating the shortcomings associated with inappropriate utilization and interpretation of routine mixing studies; and present practical steps for managing abnormal PT or PTT results.
KW - Circulating coagulation inhibitor
KW - Lupus anticoagulant
KW - Mixing study
KW - Partial thromboplastin time
KW - Prothrombin time
UR - http://www.scopus.com/inward/record.url?scp=85057109849&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057109849&partnerID=8YFLogxK
U2 - 10.1016/j.transci.2018.11.004
DO - 10.1016/j.transci.2018.11.004
M3 - Article
C2 - 30497857
AN - SCOPUS:85057109849
SN - 1473-0502
VL - 58
SP - 39
EP - 42
JO - Transfusion and Apheresis Science
JF - Transfusion and Apheresis Science
IS - 1
ER -